Advertisement

Topics

Kodiak Capital Group, LLC Company Profile

08:22 EST 13th December 2018 | BioPortfolio

Kodiak Capital Group, LLC, founded in 2009, is an operationally driven private equity firm that partners with management to make non-control equity investments in lower middle market businesses. Kodiak pursues niche-market leaders that provide high-margin products or services. Kodiak transactions typically provide liquidity to shareholders, facilitate transition of ownership to key managers, and allow management to capitalize on growth opportunities while maintaining the legacy of the founders. Kodiak has focused consistently on the lower-middle market and generated superior returns for its partners. Kodiak is currently investing in new platforms through a multitude of innovative financing solutions.


News Articles [1351 Associated News Articles listed on BioPortfolio]

Kodiak Sciences Inc. Announces Launch of Initial Public Offering

PALO ALTO, Calif., Sept. 24, 2018 /PRNewswire/ -- Kodiak Sciences Inc. ("Kodiak") today announced that it has launched an initial public offering of 9,000,000 shares Read more...

Genentech Executive Jason Ehrlich Joins Kodiak Sciences C-Suite

Kodiak Sciences has appointed Jason Ehrlich to serve as chief medical officer and chief development officer of the Palo Alto, CA, eye drug developer. Ehrlich comes to Kodiak from Roche subsidiary, Gen...

@jeff_cranmer Jeffrey Cranmer

Days after hiring Genentech vet Jason Ehrlich as CMO, ophthalmic company Kodiak Sciences files for NASDAQ #IPO. Ehrlich was lead clinician for Lucentis in diabetic eye disease. @iBonanos takes a look...

Kodiak Sciences Inc. Announces Pricing of Initial Public Offering

PALO ALTO, Calif., Oct. 3, 2018 /PRNewswire/ -- Kodiak Sciences Inc. ("Kodiak") today announced the pricing of its initial public offering of 9,000,000 shares of Read more...

Kodiak Sciences pushes ahead with trials for diabetic eye disease drug as it unveils 3Q results

Kodiak's IPO just last month raised $94m in gross proceeds, which is being put towards funding its research

Kodiak Sciences files for IPO

Ophthalmic-focused Kodiak Sciences Inc. filed for its initial public offering on the Nasdaq.

Kodiak Sciences nets $83.7mm in IPO

Ophthalmic-focused Kodiak Sciences Inc. netted $83.7mm in its initial public offering of 9mm shares at $10 on the Nasdaq. The company planned to sell 9mm shares between $13 and $15 each.

IPO Roundup: Guardant prices IPO above high end of range, while Kodiak Sciences' pricing comes up short

Cancer detection firm Guardant Health raised $237.5 million, while biotech start-up Kodiak Sciences could raise $93.15 million

PubMed Articles [1858 Associated PubMed Articles listed on BioPortfolio]

Community social capital and inequality in depressive symptoms among older Japanese adults: A multilevel study.

Although studies have suggested that community social capital contributes to narrow income-based inequality in depression, the impacts may depend on its components. Our multilevel cross-sectional anal...

Social capital insights from Healthy Settings needs assessment in Malawi.

Despite global health improvements, substantial challenges in social determinants of health and poverty remain in rural communities in low-income countries. Public health theorists suggest that commun...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Social Capital, Community Capacity, and Health.

The capacity to practice health behavior is different for each individual. Community capacity and social capital deal with understanding the relationship between community members and with the factors...

Is community social capital associated with subjective symptoms of dementia among older people? A cross-sectional study in Japan.

Many studies have reported the preventive effects of community social capital on health outcomes, such as mortality and incidence of diseases. However, evidence on the association between community so...

Clinical Trials [4163 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash Study

This study aims to compare the effect of flash glucose monitoring (FGM) with traditional self-monitoring of blood glucose (SMBG) with or without carbohydrate counting and automated bolus c...

Companies [2711 Associated Companies listed on BioPortfolio]

Kodiak Capital Group, LLC

Kodiak Capital Group, LLC, founded in 2009, is an operationally driven private equity firm that partners with management to make non-control equity investments in lower middle mar...

Human Capital Management Services Group

The Human Capital Management Services Group consists of three related companies that reduce healthcare costs, empower personal ownership of health decisions, measurably grow productivity and business ...

Crescent Capital Group LP

Crescent Capital Group LP, an SEC-registered investment adviser, is headquartered in Los Angeles with offices in Boston, London and New York. With approximately 65 investment prof...

GZ Group

GZ Group is the exclusive advisor of H&B Capital LP(1999) and Life Equity Sweden KB(2002), two life science focused venture capital funds operating in the Nordic market. The GZ Group has over 230 mill...

Arlington Group plc

The Arlington Group was originally founded back in May 1997 with £50,000 of paid up capital. The Company has traditionally been a provider of bridge finance and working capital to a range of small to...

More Information about "Kodiak Capital Group, LLC" on BioPortfolio

We have published hundreds of Kodiak Capital Group, LLC news stories on BioPortfolio along with dozens of Kodiak Capital Group, LLC Clinical Trials and PubMed Articles about Kodiak Capital Group, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kodiak Capital Group, LLC Companies in our database. You can also find out about relevant Kodiak Capital Group, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record